लोड हो रहा है...
MEK inhibitors for the treatment of NRAS mutant melanoma
Melanoma is increasing rapidly in incidence and prevalence, especially in younger females and older males. Treatment options have expanded beyond high-dose interleukin 2 and adoptive T-cell therapy to include inhibitors of immune checkpoints programmed death 1 (PD-1) and cytotoxic T-lymphocyte-assoc...
में बचाया:
| में प्रकाशित: | Drug Des Devel Ther |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Dove Medical Press
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6108333/ https://ncbi.nlm.nih.gov/pubmed/30154648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S131721 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|